event,time
61 years old ,0
    woman ,0
    admitted to the hospital ,0
    general weakness ,0
    fall at home ,0
    infected heel pressure ulcer ,0
    admitted to the Department of General Surgery ,0
    urinary tract infection ,0
    thyroid dysfunction ,0
    hemodynamic instability ,6
    loss of consciousness ,6
    admitted to the intensive care unit ,6
    intubated ,6
    unconscious ,6
    hypothermic ,6
    temperature 35.8°C ,6
    hypotensive ,6
    systolic blood pressure 75 mm Hg ,6
    bradycardic ,6
    heart rate 45 beats per min ,6
    obese ,6
    body mass index of 36 ,6
    generalized subcutaneous edema ,6
    marked in the lower limbs ,6
    large areas of macerated skin ,6
    extensive heel pressure ulcer ,6
    surgical revision ,6
    soft abdomen ,6
    inaudible peristalsis ,6
    irreducible ventral hernia ,6
    no features of occlusion ,6
    hypercapnia ,6
    compensated respiratory acidosis ,6
    arterial blood pH of 7.36 ,6
    elevated serum bicarbonate ,6
    HCO3 32 mEq/L ,6
    hypomagnesemia ,6
    0.5 mmol/L ,6
    hypophosphatemia ,6
    0.4 mmol/L ,6
    severe hypoalbuminemia ,6
    20 g/L ,6
    CRP level of 34 mg/L ,6
    WBC count of 5.7 × 109 cells/L ,6
    thyroxine T4 1.0 nmol/L ,6
    TSH >100 mU/L ,6
    extreme thyroid insufficiency ,6
    myxedema ,6
    fluid resuscitation ,6
    inotropic support ,6
    hormonal substitution ,6
    intravenous T4 500 μg ,6
    T4 100 μg/day ,6
    intravenous triiodothyronine T3 5 μg × 3/day ,6
    suspected sepsis ,6
    urinary tract infection ,6
    heel pressure ulcer ,6
    initial empirical intravenous piperacillin/tazobactam therapy ,6
    4 g × 3/day ,6
    replaced with cefuroxime ,144
    1.5 g × 3/day ,144
    metronidazole ,144
    500 mg × 3/day ,144
    metronidazole withdrawn ,168
    urine culture ,168
    lower limb wound ,168
    Escherichia coli ,168
    Corynobacterium ,168
    hemodynamic stabilization ,168
    intravenous hormonal medication reduced ,168
    oral T4 ,168
    serum thyroid hormones normalized ,168
    extubated ,168
    gradual increase in CRP level ,168
    CRP 156 ng/L ,168
    emergence of clinical signs of pneumonia ,168
    radiological signs of pneumonia ,168
    cefuroxime replaced with piperacillin/tazobactam ,168
    CRP increased to 206 ng/L ,192
    no fever ,192
    no increase in WBC count ,192
    abdomen still silent ,192
    moderately distended ,192
    no signs of bowel movement ,192
    enteral nutrition ,192
    computed tomography ,192
    considerable amount of fecal content in the colon and rectum ,192
    significant expansion up to 9 cm in diameter ,192
    enhancement and edema of sigmoid and rectal wall ,192
    bowel obstruction ,192
    enemas ,192
    violent and abundant diarrhea ,192
    CDI ,192
    diagnosis of CDI confirmed ,480
    PCR test ,480
    BD MAX Cdiff assay ,480
    GeneXpert ,480
    enteral vancomycin ,480
    250 mg × 4/day ,480
    persistent diarrhea ,480
    replaced with metronidazole ,528
    500 mg × 3/day ,528
    enteral fidaxomicin ,528
    200 mg × 2/day ,528
    intravenous tigecycline ,528
    100 mg initially ,528
    50 mg × 2/day ,528
    piperacillin/tazobactam stopped ,528
    no clinical improvement ,528
    lack of response to treatment ,528
    colonoscopy findings ,528
    extensive swelling of the mucous membrane ,528
    no pseudomembranous formations ,528
    fecal microbiota transplant ,528
    frozen stool from healthy donor ,528
    donor screened for pathogens ,528
    fecal microbiota transplantation procedure ,528
    500 mL liquid suspension ,528
    5 enema portions ,528
    diarrhea disappeared ,528
    no adverse effects ,528
    rapid decrease in CRP levels ,528
    recovery from myxedema ,528
    no problems from digestive tract ,528
    discharged to ordinary ward ,1560
    65 days in ICU ,1560
